Background: Secondary lesions can occur in tissues surrounding the
Background: This study aimed to study the dynamic changes of B cell
Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) is present mai
Aim: To evaluate the efficacy and safety of 3,000 mg daily levetira
Purpose: The purpose of this study was to investigate the current c